Related Experiment Video
Updated: Aug 11, 2026
09:33
Quantitative 3D In Silico Modeling (q3DISM) of Cerebral Amyloid-beta Phagocytosis in Rodent Models of Alzheimer's Disease
Published on: December 26, 2016
Qualitative research and Alzheimer disease
1Center for Nursing Science and Scholarly Practice, University of Rochester, School of Nursing, New York 14642, USA.
Alzheimer Disease and Associated Disorders
|June 16, 1999
Summary
Qualitative research methods offer valuable insights into Alzheimer disease by exploring patient experiences. This study details ethnography and grounded theory approaches for advancing Alzheimer disease knowledge.
Area of Science:
- Gerontology
- Medical Sociology
- Qualitative Research Methods
Background:
- Alzheimer disease (AD) research benefits from understanding patient lived experiences.
- Qualitative methods provide a framework for exploring complex human experiences in AD.
Purpose of the Study:
- To provide an overview of qualitative research methods.
- To illustrate their utility in uncovering new knowledge about Alzheimer disease.
- To discuss philosophical underpinnings and standards for qualitative research.
Main Methods:
- Discussion of philosophical assumptions and standards for qualitative research.
- Detailed presentation of ethnography and grounded theory approaches.
- Illustrative examples from published studies demonstrating methodological fit.
Main Results:
- Qualitative methods, specifically ethnography and grounded theory, offer robust frameworks for AD research.
- Demonstrated logical consistency between purpose, data collection, analysis, and results for chosen methods.
- Highlighted practical considerations for data management and publication in qualitative research.
Conclusions:
- Qualitative research methods are essential for exploring and interpreting the multifaceted experiences of individuals with Alzheimer disease.
- Ethnography and grounded theory are effective approaches for generating novel insights into AD.
- Effective data management and publication strategies are crucial for disseminating qualitative findings in AD research.
More Related Videos
Related Concept Videos
01:26Alzheimer's Disease: Overview
Alzheimer's Disease (AD) is a continually advancing neurodegenerative disorder, distinguished by escalating memory loss, cognitive dysfunction, and dementia. The disease unfolds in three stages: preclinical, mild cognitive impairment (MCI), and dementia. Its onset is insidious, and the progression gradual, with the cause not well explained by other disorders.
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ and tau...
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ and tau...
01:22Alzheimer's Disease: Treatment
Alzheimer's Disease (AD), a neurodegenerative disorder, is pathologically identified by amyloid plaques and neurofibrillary tangles composed of tau protein. AD pharmacotherapy aims to manage cognitive symptoms, delay disease progression, and treat behavioral symptoms. The treatment is primarily symptomatic and palliative, with no definitive disease-modifying therapy available. Cholinesterase inhibitors, including donepezil (Aricept), rivastigmine (Exelon), and galantamine (Razadyne), are...
01:30Dementia
Dementia is a collective term for cognitive disorders primarily affecting memory, thinking, and reasoning. It is not a specific disease but a syndrome, with Alzheimer's disease being the most common cause, accounting for approximately 60-80% of cases. Other types include vascular dementia, Lewy body dementia, and frontotemporal dementia. Dementia affects millions worldwide, particularly older adults, though it is not a normal part of aging.
The progression of dementia is generally gradual.
The progression of dementia is generally gradual.
01:29Alzheimer Disease l: Introduction
Alzheimer disease is a chronic, progressive, and irreversible neurodegenerative disorder and the most common cause of dementia in older adults. It leads to gradual neuronal loss, causing cognitive decline, behavioral changes, and loss of functional independence.Risk Factors and EtiologyThe disease is multifactorial. Age is the strongest risk factor, with prevalence doubling every 5 years after age 65. Genetic factors include mutations in genes such as APP, PSEN1, and PSEN2, which are associated...
01:23Alzheimer Disease ll: Pathophysiology
Alzheimer disease involves structural changes in the brain that begin long before symptoms appear. The most distinctive features are extracellular neuritic plaques and intracellular neurofibrillary tangles.Neuritic plaques form in the cerebral cortex and around blood vessels. These plaques contain a dense core of beta-amyloid (Aβ)—a toxic protein fragment that clumps outside neurons. The core is surrounded by damaged neuronal extensions, as well as reactive astrocytes and microglia. Abnormal...
01:22Dementia l: Introduction
Dementia is an acquired, progressive syndrome characterized by a decline in multiple cognitive domains severe enough to impair daily functioning and reduce independence. Although memory loss is a central feature, the diagnosis requires additional deficits involving language, executive function, visuospatial skills, judgment, calculation, or abstract reasoning. These cognitive impairments reflect underlying neurodegenerative or vascular processes that gradually disrupt neuronal networks...